Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2018 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results.
Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, Mueller D, Eismant A, Almaguel F, Zboralski D, Osterkamp F, Hoehne A, Reineke U, Smerling C, Kulkarni HR. Baum RP, et al. Among authors: robiller fc. J Nucl Med. 2022 Mar;63(3):415-423. doi: 10.2967/jnumed.120.259192. Epub 2021 Jun 24. J Nucl Med. 2022. PMID: 34168013 Free PMC article.
Primary Neuroendocrine Neoplasia of the Liver.
Kaemmerer D, Kunze A, Robiller FC, Hommann M, Anlauf M. Kaemmerer D, et al. Among authors: robiller fc. Clin Nucl Med. 2021 May 1;46(5):409-410. doi: 10.1097/RLU.0000000000003530. Clin Nucl Med. 2021. PMID: 33630790
Treatable Sydenham Chorea in a 76-Year-Old Woman.
Stuetzer A, Strasilla C, Robiller FC, Kunze A. Stuetzer A, et al. Among authors: robiller fc. Neurology. 2023 Nov 7;101(19):859-860. doi: 10.1212/WNL.0000000000207640. Epub 2023 Aug 14. Neurology. 2023. PMID: 37580160 Free PMC article. No abstract available.
Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms.
Baum RP, Kulkarni HR, Singh A, Kaemmerer D, Mueller D, Prasad V, Hommann M, Robiller FC, Niepsch K, Franz H, Jochems A, Lambin P, Hörsch D. Baum RP, et al. Among authors: robiller fc. Oncotarget. 2018 Feb 15;9(24):16932-16950. doi: 10.18632/oncotarget.24524. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29682195 Free PMC article.